HK1198741A1 - New (trimethoxyphenylamino)pyrimidinyl formulations () - Google Patents
New (trimethoxyphenylamino)pyrimidinyl formulations ()Info
- Publication number
- HK1198741A1 HK1198741A1 HK14112235.4A HK14112235A HK1198741A1 HK 1198741 A1 HK1198741 A1 HK 1198741A1 HK 14112235 A HK14112235 A HK 14112235A HK 1198741 A1 HK1198741 A1 HK 1198741A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trimethoxyphenylamino
- pyrimidinyl
- formulations
- new
- pyrimidinyl formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512621P | 2011-07-28 | 2011-07-28 | |
| PCT/GB2012/051791 WO2013014454A1 (fr) | 2011-07-28 | 2012-07-26 | Nouvelles formulations de (triméthoxyphénylamino)pyrimidinyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1198741A1 true HK1198741A1 (en) | 2015-06-05 |
Family
ID=46875902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14112235.4A HK1198741A1 (en) | 2011-07-28 | 2014-12-04 | New (trimethoxyphenylamino)pyrimidinyl formulations () |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8771648B2 (fr) |
| EP (1) | EP2736487B1 (fr) |
| JP (1) | JP6019116B2 (fr) |
| KR (2) | KR102090440B1 (fr) |
| CN (1) | CN103826610B (fr) |
| AR (1) | AR087371A1 (fr) |
| AU (1) | AU2012288632B2 (fr) |
| BR (1) | BR112014001999B1 (fr) |
| CA (1) | CA2843138C (fr) |
| CY (1) | CY1122596T1 (fr) |
| DK (1) | DK2736487T3 (fr) |
| EA (1) | EA028432B1 (fr) |
| ES (1) | ES2710423T3 (fr) |
| HK (1) | HK1198741A1 (fr) |
| HR (1) | HRP20190186T1 (fr) |
| HU (1) | HUE042611T2 (fr) |
| LT (1) | LT2736487T (fr) |
| MX (1) | MX339685B (fr) |
| PL (1) | PL2736487T3 (fr) |
| PT (1) | PT2736487T (fr) |
| RS (1) | RS58433B1 (fr) |
| SI (1) | SI2736487T1 (fr) |
| TR (1) | TR201901792T4 (fr) |
| TW (1) | TW201311251A (fr) |
| UY (1) | UY34223A (fr) |
| WO (1) | WO2013014454A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2380551T3 (es) * | 2006-11-21 | 2012-05-16 | Rigel Pharmaceuticals, Inc. | Sales de profármaco de compuestos de 2,4-pirimidindiamina y sus usos |
| CA2843138C (fr) | 2011-07-28 | 2020-06-02 | Rigel Pharmaceuticals, Inc. | Nouvelles formulations de (trimethoxyphenylamino)pyrimidinyle |
| JP6853786B2 (ja) | 2015-04-02 | 2021-03-31 | ストラ エンソ オーワイジェイ | 活性化リグニン組成物、その製造方法及びその使用 |
| WO2016172053A1 (fr) | 2015-04-24 | 2016-10-27 | Rigel Pharmaceuticals, Inc. | Méthodes de traitement d'une maladie résistante à l'ibrutinib |
| EP4185126A1 (fr) * | 2020-07-24 | 2023-05-31 | DSM IP Assets B.V. | Nouveaux comprimés à dissolution rapide |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| CN103169708B (zh) | 2002-07-29 | 2018-02-02 | 里格尔药品股份有限公司 | 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
| RS53109B (en) | 2003-07-30 | 2014-06-30 | Rigel Pharmaceuticals Inc. | 2,4 PIRIMIDINDIAMINE COMPOUNDS FOR USE IN TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES |
| DK1663242T3 (da) | 2003-08-07 | 2011-08-01 | Rigel Pharmaceuticals Inc | 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler |
| US20060051406A1 (en) * | 2004-07-23 | 2006-03-09 | Manjeet Parmar | Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| EP1794135A1 (fr) * | 2004-09-27 | 2007-06-13 | Amgen Inc. | Composes heterocycliques substitues et procedes d'utilisation |
| ES2337496T3 (es) * | 2005-01-19 | 2010-04-26 | Rigel Pharmaceuticals, Inc. | Profarmacos de compuestos de 2,4-pirimidindiamina y sus usos. |
| US8227455B2 (en) | 2005-04-18 | 2012-07-24 | Rigel Pharmaceuticals, Inc. | Methods of treating cell proliferative disorders |
| JP2009518443A (ja) * | 2005-12-06 | 2009-05-07 | リゲル ファーマシューティカルズ インコーポレーティッド | 脂質を主材料とする担体に内封された、不溶性小分子治療剤の製剤 |
| CA2642211C (fr) * | 2006-02-17 | 2012-01-24 | Rigel Pharmaceuticals, Inc. | Composes de 2,4-pyrimidinediamine pour le traitement ou la prevention de maladies autoimmunes |
| US20090048214A1 (en) * | 2006-11-15 | 2009-02-19 | Rigel Pharmaceuticals, Inc | Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds |
| ES2380551T3 (es) * | 2006-11-21 | 2012-05-16 | Rigel Pharmaceuticals, Inc. | Sales de profármaco de compuestos de 2,4-pirimidindiamina y sus usos |
| US20090012045A1 (en) * | 2007-06-26 | 2009-01-08 | Rigel Pharmaceuticals, Inc. | Methods of Treating Cell Proliferative Disorders |
| WO2009029682A1 (fr) * | 2007-08-28 | 2009-03-05 | Rigel Pharmaceuticals, Inc. | Thérapie de combinaison avec un inhibiteur de la kinase syk |
| EA020210B1 (ru) * | 2007-11-07 | 2014-09-30 | Райджел Фармасьютикалз, Инк. | Влажное гранулирование с использованием вещества, связывающего воду |
| DK2252300T3 (en) | 2008-02-22 | 2017-02-06 | Rigel Pharmaceuticals Inc | USE OF 2,4-PYRIMIDINE DIAMINES TO TREAT Atherosclerosis |
| UA108077C2 (xx) | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну | |
| WO2011009075A2 (fr) | 2009-07-17 | 2011-01-20 | Rigel Pharmaceuticals, Inc. | Composés 2,4-pyrimidine diamine deutérés et leurs promédicaments et leurs utilisations |
| WO2011063241A1 (fr) | 2009-11-20 | 2011-05-26 | Rigel Pharmaceuticals, Inc. | Composés 2,4-pyrimidinediamines et promédicaments de ceux-ci et leurs utilisations |
| JP6067550B2 (ja) | 2010-04-13 | 2017-01-25 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ２，４−ピリミジンジアミン化合物およびそのプロドラッグならびにそれらの使用 |
| CA2843138C (fr) | 2011-07-28 | 2020-06-02 | Rigel Pharmaceuticals, Inc. | Nouvelles formulations de (trimethoxyphenylamino)pyrimidinyle |
-
2012
- 2012-07-26 CA CA2843138A patent/CA2843138C/fr active Active
- 2012-07-26 RS RS20190146A patent/RS58433B1/sr unknown
- 2012-07-26 KR KR1020197027074A patent/KR102090440B1/ko active IP Right Grant
- 2012-07-26 DK DK12759802.7T patent/DK2736487T3/en active
- 2012-07-26 TR TR2019/01792T patent/TR201901792T4/tr unknown
- 2012-07-26 PT PT12759802T patent/PT2736487T/pt unknown
- 2012-07-26 CN CN201280046605.3A patent/CN103826610B/zh active Active
- 2012-07-26 UY UY0001034223A patent/UY34223A/es unknown
- 2012-07-26 WO PCT/GB2012/051791 patent/WO2013014454A1/fr active Application Filing
- 2012-07-26 EA EA201490363A patent/EA028432B1/ru unknown
- 2012-07-26 KR KR1020147004810A patent/KR102024120B1/ko active IP Right Grant
- 2012-07-26 SI SI201231519T patent/SI2736487T1/sl unknown
- 2012-07-26 EP EP12759802.7A patent/EP2736487B1/fr active Active
- 2012-07-26 BR BR112014001999-1A patent/BR112014001999B1/pt active IP Right Grant
- 2012-07-26 ES ES12759802T patent/ES2710423T3/es active Active
- 2012-07-26 MX MX2014001065A patent/MX339685B/es active IP Right Grant
- 2012-07-26 AU AU2012288632A patent/AU2012288632B2/en active Active
- 2012-07-26 JP JP2014522154A patent/JP6019116B2/ja active Active
- 2012-07-26 PL PL12759802T patent/PL2736487T3/pl unknown
- 2012-07-26 LT LTEP12759802.7T patent/LT2736487T/lt unknown
- 2012-07-26 HU HUE12759802A patent/HUE042611T2/hu unknown
- 2012-07-27 US US13/559,805 patent/US8771648B2/en active Active
- 2012-07-27 AR ARP120102755A patent/AR087371A1/es not_active Application Discontinuation
- 2012-07-27 TW TW101127261A patent/TW201311251A/zh unknown
-
2014
- 2014-05-29 US US14/290,494 patent/US8951504B2/en active Active
- 2014-12-04 HK HK14112235.4A patent/HK1198741A1/xx unknown
-
2019
- 2019-01-29 HR HRP20190186TT patent/HRP20190186T1/hr unknown
- 2019-02-06 CY CY20191100159T patent/CY1122596T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI563077B (en) | Cleaning formulations | |
| HRP20181896T1 (hr) | Farmaceutske formulacije | |
| IL227896B (en) | Freeze-dried formulations | |
| HRP20190186T1 (hr) | Nove formulacije (trimetoksifenilamino)pirimidinila | |
| EP2755680A4 (fr) | Formulations vaccinales particulaires | |
| SI2753311T1 (sl) | Formulacije antioksidanta | |
| EP2934482A4 (fr) | Formulations de rétention gastrique | |
| GB201114725D0 (en) | Ophthalmic formulations | |
| PL2908835T3 (pl) | Stabilne formulacje | |
| EP2729164A4 (fr) | Formulations stabilisant des protéines | |
| EP2782585A4 (fr) | Préparations antivirales | |
| GB201110278D0 (en) | Formulations | |
| GB201221125D0 (en) | Pharmaceutial formulations | |
| GB201111578D0 (en) | Pharmeutical formulations | |
| GB201111013D0 (en) | Formulations | |
| GB201107626D0 (en) | Formulations | |
| GB201107627D0 (en) | Formulations | |
| GB201105410D0 (en) | Formulations | |
| GB201105360D0 (en) | Formulations | |
| GB201104049D0 (en) | Formulations | |
| GB201104048D0 (en) | Formulations | |
| GB201102795D0 (en) | Formulations | |
| GB201206178D0 (en) | Formulations | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201103767D0 (en) | Cosmetic formulations |